Skip to main content

Table 1 Clinical features and follow-ups

From: Amphicrine carcinoma of the stomach and intestine: a clinicopathologic and pan-cancer transcriptome analysis of a distinct entity

CaseGenderAge (years)Specimen typePositionGrossSize (cm)TNMStageaPlLVITreatmentOutcomes
1M61ResectionGastric bodyUlcerative5.5T41/170IIIANPSurgery + chemotherapyNED, 63 months
2M61BiopsyGastric antrumNANAT1NANANANANANANED, 12 months
3M58ResectionGastric antrumUlcerativeNAT20/180IBNNSurgeryNED, 10 months
4M63ResectionGastric antrumUlcerative3.0T10/270IANNSurgeryNED, 10 months
5M56ResectionGastric bodyUlcerative2.5T46/150IIIANPSurgeryDOD, 42 months
6M68ResectionGastric antrumUlcerative4.5T428/470IIICPPSurgery + chemotherapyNED, 12 months
7M60ResectionGastric cardiaUlcerative2T41/210IIIAPNSurgeryDOD, 11 months
8M65BiopsyRectumFungating5NANA1bNANANAPalliative radiotherapy and chemotherapyDOD, 12 months, liver and lung metastasis
9M67ResectionGastric cardiaUlcerative3.5T30/160NANPSurgery + chemotherapyNED, 6 months
10M69BiopsyRectumFungating3.0cT4NA1bNANANAChemotherapyAWD, 33 months, liver metastasis
  1. M Male, PI perineural invasion, LVI lymphovascular invasion, P positive, N negative, NA not available, AWD alive with disease, DOD dead of disease, NED no evidence of disease
  2. aStage is according to the AJCC 8th edition gastric cancer staging system
  3. bWith synchronous liver metastases